BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25876231)

  • 1. Qualitative and quantitative modifications of von Willebrand factor in patients with essential thrombocythemia and controlled platelet count.
    Lancellotti S; Dragani A; Ranalli P; Petrucci G; Basso M; Tartaglione R; Rocca B; De Cristofaro R
    J Thromb Haemost; 2015 Jul; 13(7):1226-37. PubMed ID: 25876231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased cleavage of von Willebrand factor by ADAMTS13 may contribute strongly to acquired von Willebrand syndrome development in patients with essential thrombocythemia.
    Kubo M; Sakai K; Hayakawa M; Kashiwagi H; Yagi H; Seki Y; Hasegawa A; Tanaka H; Amano I; Tomiyama Y; Matsumoto M
    J Thromb Haemost; 2022 Jul; 20(7):1589-1598. PubMed ID: 35352474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The reduction of large von Willebrand factor multimers in plasma in essential thrombocythaemia is related to the platelet count.
    van Genderen PJ; Budde U; Michiels JJ; van Strik R; van Vliet HH
    Br J Haematol; 1996 Jun; 93(4):962-5. PubMed ID: 8703834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.
    Michiels JJ; Berneman Z; Schroyens W; Finazzi G; Budde U; van Vliet HH
    Semin Thromb Hemost; 2006 Sep; 32(6):589-604. PubMed ID: 16977569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased half-life time of plasma von Willebrand factor collagen binding activity in essential thrombocythaemia: normalization after cytoreduction of the increased platelet count.
    van Genderen PJ; Prins FJ; Lucas IS; van de Moesdijk D; van Vliet HH; van Strik R; Michiels JJ
    Br J Haematol; 1997 Dec; 99(4):832-6. PubMed ID: 9432029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired von Willebrand factor deficiency caused by LVAD is ADAMTS-13 and platelet dependent.
    Jilma-Stohlawetz P; Quehenberger P; Schima H; Stoiber M; Knöbl P; Steinlechner B; Felli A; Jilma B
    Thromb Res; 2016 Jan; 137():196-201. PubMed ID: 26616301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excessive prolongation of the bleeding time by aspirin in essential thrombocythemia is related to a decrease of large von Willebrand factor multimers in plasma.
    van Genderen PJ; van Vliet HH; Prins FJ; van de Moesdijk D; van Strik R; Zijlstra FJ; Budde U; Michiels JJ
    Ann Hematol; 1997; 75(5-6):215-20. PubMed ID: 9433378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between ADAMTS13 activity, von Willebrand factor antigen levels and platelet function in the early and late phases after TIA or ischaemic stroke.
    McCabe DJ; Murphy SJ; Starke R; Harrison P; Brown MM; Sidhu PS; Mackie IJ; Scully M; Machin SJ
    J Neurol Sci; 2015 Jan; 348(1-2):35-40. PubMed ID: 25498844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of von Willebrand factor in essential thrombocythemia patients treated with alpha-2b recombinant interferon.
    Mazzucconi MG; Ferrari A; Solinas S; Vitale A; Chistolini A; Federici AB; Mandelli F
    Haemostasis; 1991; 21(3):135-40. PubMed ID: 1773983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADAMTS-13 activity in the presence of elevated von Willebrand factor levels as a novel mechanism of residual platelet reactivity in high risk coronary patients on antiplatelet treatment.
    Marcucci R; Cesari F; Cinotti S; Paniccia R; Gensini GF; Abbate R; Gori AM
    Thromb Res; 2008; 123(1):130-6. PubMed ID: 18603284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct evidence for normalization of platelet function resulting from platelet count reduction in essential thrombocythemia.
    Tsantes AE; Nikolopoulos GK; Tsirigotis P; Zoi K; Zomas A; Kapsimali V; Kopterides P; Chondropoulos S; Dervenoulas J; Mantzios G
    Blood Coagul Fibrinolysis; 2011 Sep; 22(6):457-62. PubMed ID: 21836466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet reactive conformation and multimeric pattern of von Willebrand factor in acquired thrombotic thrombocytopenic purpura during acute disease and remission.
    Lotta LA; Lombardi R; Mariani M; Lancellotti S; De Cristofaro R; Hollestelle MJ; Canciani MT; Mannucci PM; Peyvandi F
    J Thromb Haemost; 2011 Sep; 9(9):1744-51. PubMed ID: 21726405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors related to the development of acquired von Willebrand syndrome in patients with essential thrombocythemia and polycythemia vera.
    Rottenstreich A; Kleinstern G; Krichevsky S; Varon D; Lavie D; Kalish Y
    Eur J Intern Med; 2017 Jun; 41():49-54. PubMed ID: 27919526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of procoagulant potential in patients with reactive thrombocytosis and its association with platelet count.
    Rottenstreich A; Shai E; Kleinstern G; Spectre G; Varon D; Kalish Y
    Eur J Haematol; 2018 Mar; 100(3):286-293. PubMed ID: 29240268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of methionine sulfoxide by peroxynitrite at position 1606 of von Willebrand factor inhibits its cleavage by ADAMTS-13: A new prothrombotic mechanism in diseases associated with oxidative stress.
    Lancellotti S; De Filippis V; Pozzi N; Peyvandi F; Palla R; Rocca B; Rutella S; Pitocco D; Mannucci PM; De Cristofaro R
    Free Radic Biol Med; 2010 Feb; 48(3):446-56. PubMed ID: 19969076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemia.
    Trappenburg MC; van Schilfgaarde M; Marchetti M; Spronk HM; ten Cate H; Leyte A; Terpstra WE; Falanga A
    Haematologica; 2009 Jul; 94(7):911-8. PubMed ID: 19508974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteinases.
    Gardiner EE; Karunakaran D; Shen Y; Arthur JF; Andrews RK; Berndt MC
    J Thromb Haemost; 2007 Jul; 5(7):1530-7. PubMed ID: 17445093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombocytapheresis for acquired von Willebrand syndrome in a patient with essential thrombocythemia and recent multivisceral transplantation.
    Oyedeji O; Sheqwara J; Onwubiko I; Lopez-Plaza I; Nagai S; Otrock ZK
    Transfusion; 2021 Nov; 61(11):3277-3280. PubMed ID: 34569071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with Essential Thrombocythemia may be Poor Responders to Enteric-Coated Aspirin, but not to Plain Aspirin.
    Scavone M; Rizzo J; Femia EA; Podda GM; Bossi E; Caberlon S; Paroni R; Cattaneo M
    Thromb Haemost; 2020 Oct; 120(10):1442-1453. PubMed ID: 32717754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated platelet count as a cause of abnormal von Willebrand factor multimer distribution in plasma.
    Budde U; Scharf RE; Franke P; Hartmann-Budde K; Dent J; Ruggeri ZM
    Blood; 1993 Sep; 82(6):1749-57. PubMed ID: 8400231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.